{
 "name": "永日",
 "slug": "tw-4102",
 "aliases": [
  "永日化學工業股份有限公司",
  "YUNGZIP",
  "4102"
 ],
 "ticker": "4102",
 "industry": "生技醫療業",
 "website": "http://www.yungzip.com",
 "summary": "永日（4102）是上櫃的生技醫療類股公司，1978 年成立，2001 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "永日化學工業股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "YUNGZIP",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2001-03-20",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "1978-06-08",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "林青煌",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "李育儒",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 423734430,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.yungzip.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 31225,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -12.19,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 6.64,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "主要產品：DCS（Diclofenac Sodium）",
   "value": "消炎及鎮痛原料藥",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "年報列為商品；FDA查廠、DMF或CEP均不等同成品上市許可，未填產品許可。"
  },
  {
   "claim": "主要產品：ACV（Acyclovir）",
   "value": "抗病毒原料藥",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "年報列為商品；FDA查廠、DMF或CEP均不等同成品上市許可，未填產品許可。"
  },
  {
   "claim": "主要產品：MCN（Miconazole Nitrate）",
   "value": "抗黴菌及相關感染原料藥",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "年報列為商品；FDA查廠、DMF或CEP均不等同成品上市許可，未填產品許可。"
  },
  {
   "claim": "主要產品：CLD（Clonidine Hydrochloride）",
   "value": "抗高血壓原料藥",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "年報列為商品；FDA查廠、DMF或CEP均不等同成品上市許可，未填產品許可。"
  },
  {
   "claim": "主要產品：DCP（Diclofenac Potassium）",
   "value": "解熱鎮痛消炎原料藥",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "年報列為商品；FDA查廠、DMF或CEP均不等同成品上市許可，未填產品許可。"
  },
  {
   "claim": "管線：TOP",
   "value": "低血鈉症治療用原料藥｜新產品開發｜地區未披露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "公司原料藥製程開發項目；不代表創新藥人體臨床期別。年報未列商品名、學名、試驗登錄或目標市場。"
  },
  {
   "claim": "管線：PLB",
   "value": "局部麻醉劑原料藥｜新產品開發｜地區未披露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "公司原料藥製程開發項目；不代表創新藥人體臨床期別。年報未列商品名、學名、試驗登錄或目標市場。"
  },
  {
   "claim": "管線：DAT",
   "value": "貧血症用原料藥｜新產品開發｜地區未披露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "公司原料藥製程開發項目；不代表創新藥人體臨床期別。年報未列商品名、學名、試驗登錄或目標市場。"
  },
  {
   "claim": "管線：RCG",
   "value": "肺動脈高壓治療用原料藥｜新產品開發｜地區未披露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "公司原料藥製程開發項目；不代表創新藥人體臨床期別。年報未列商品名、學名、試驗登錄或目標市場。"
  },
  {
   "claim": "管線：CPS",
   "value": "中風、心肌梗塞用原料藥｜新產品開發｜地區未披露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.yungzip.com/archive/download/item/114年報/股東會年報.pdf",
   "note": "公司原料藥製程開發項目；不代表創新藥人體臨床期別。年報未列商品名、學名、試驗登錄或目標市場。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-4102.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}